Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Proteasome inhibition alleviates SNARE-dependent neurodegeneration.

Sharma M, Burré J, Südhof TC.

Sci Transl Med. 2012 Aug 15;4(147):147ra113. doi: 10.1126/scitranslmed.3004028.

2.

New therapeutic strategy for Parkinson's and Alzheimer's disease.

Esposito E, Cuzzocrea S.

Curr Med Chem. 2010;17(25):2764-74. Review.

PMID:
20586718
3.

Misframed proteins and neurodegeneration: a novel view on Alzheimer's and Parkinson's diseases.

Dennissen FJ, Kholod N, Steinbusch HW, Van Leeuwen FW.

Neurodegener Dis. 2010;7(1-3):76-9. doi: 10.1159/000285510. Review.

PMID:
20173331
4.

Ubiquitin proteasome system as a pharmacological target in neurodegeneration.

Hol EM, Fischer DF, Ovaa H, Scheper W.

Expert Rev Neurother. 2006 Sep;6(9):1337-47. Review.

PMID:
17009921
5.
6.

Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system.

van Leeuwen FW, Hol EM, Fischer DF.

J Alzheimers Dis. 2006;9(3 Suppl):319-25. Review.

PMID:
16914870
7.

K63-linked ubiquitination and neurodegeneration.

Lim KL, Lim GG.

Neurobiol Dis. 2011 Jul;43(1):9-16. doi: 10.1016/j.nbd.2010.08.001. Review.

PMID:
20696248
8.

Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.

Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S.

Ann N Y Acad Sci. 1999;893:154-75. Review.

PMID:
10672236
9.
10.

Neurodegenerative pathways in Parkinson's disease: therapeutic strategies.

Cardoso SM, Moreira PI, Agostinho P, Pereira C, Oliveira CR.

Curr Drug Targets CNS Neurol Disord. 2005 Aug;4(4):405-19. Review.

PMID:
16101557
11.

The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.

Hol EM, van Leeuwen FW, Fischer DF.

Trends Mol Med. 2005 Nov;11(11):488-95. Review.

PMID:
16213790
12.

Removing protein aggregates: the role of proteolysis in neurodegeneration.

Nijholt DA, De Kimpe L, Elfrink HL, Hoozemans JJ, Scheper W.

Curr Med Chem. 2011;18(16):2459-76. Review.

PMID:
21568912
13.

Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.

Moore DJ, Dawson VL, Dawson TM.

Neuromolecular Med. 2003;4(1-2):95-108. Review.

PMID:
14528055
14.

Does autophagy worsen or improve the survival of dopaminergic neurons?

Pasquali L, Ruggieri S, Murri L, Paparelli A, Fornai F.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S24-7. doi: 10.1016/S1353-8020(09)70830-2. Review.

PMID:
20123552
15.

Cysteine string protein (CSP) and its role in preventing neurodegeneration.

Burgoyne RD, Morgan A.

Semin Cell Dev Biol. 2015 Apr;40:153-9. doi: 10.1016/j.semcdb.2015.03.008. Review.

16.

[Significance of increased and reduced proteasome activity in the pathomechanism of selected disorders].

Tylicka M, Matuszczak E, Karpińska M, Dębek W.

Postepy Hig Med Dosw (Online). 2016 May 5;70:448-58. Review. Polish.

17.

[The mechanism of proteasome inhibition-mediated mitochondrial impairment].

Hoseki J.

Seikagaku. 2016 Apr;88(2):211-4. Review. Japanese. No abstract available.

PMID:
27192873
Items per page

Supplemental Content

Support Center